Isomorphic Labs

100 New Bridge Street
EC4V 6JA London
UK

Contact WebSite

Article

Isomorphic Labs to Collaborate with Eli Lilly and Novartis
10.01.2024 • News

Isomorphic Labs to Collaborate with Eli Lilly and Novartis

Isomorphic Labs announced strategic collaborations with leading pharmaceutical companies, Eli Lilly and Company and Novartis. These partnerships have the potential to be worth nearly €2.75 billion ($3 billion) to Isomorphic Labs, excluding any royalties that may result from future drug sales. Both collaborations are multi-target, focused on small molecules, and include a combination of upfront and milestone payments.